Johnson DE

References (5)

Title : An update on potential pharmacotherapies for cognitive impairment in bipolar disorder - Johnson_2023_Expert.Opin.Pharmacother__1
Author(s) : Johnson DE , McIntyre RS , Mansur RB , Rosenblat JD
Ref : Expert Opin Pharmacother , :1 , 2023
PubMedID: 36946229

Title : A novel series of [3.2.1] azabicyclic biaryl ethers as alpha3beta4 and alpha6\/4beta4 nicotinic receptor agonists - Lowe_2010_Bioorg.Med.Chem.Lett_20_4749
Author(s) : Lowe JA, 3rd , DeNinno SL , Coe JW , Zhang L , Mente S , Hurst RS , Mather RJ , Ward KM , Shrikhande A , Rollema H , Johnson DE , Horner W , Gorczyca R , Tingley FD, 3rd , Kozak R , Majchrzak MJ , Tritto T , Sadlier J , Shaffer CL , Ellerbrock B , Osgood SM , MacDougall MC , McDowell LL
Ref : Bioorganic & Medicinal Chemistry Lett , 20 :4749 , 2010
PubMedID: 20663668

Title : Preclinical pharmacology of the alpha4beta2 nAChR partial agonist varenicline related to effects on reward, mood and cognition - Rollema_2009_Biochem.Pharmacol_78(7)_813
Author(s) : Rollema H , Hajos M , Seymour PA , Kozak R , Majchrzak MJ , Guanowsky V , Horner WE , Chapin DS , Hoffmann WE , Johnson DE , McLean S , Freeman J , Williams KE
Ref : Biochemical Pharmacology , 78 :813 , 2009
PubMedID: 19501054

Title : The role of muscarinic receptor antagonism in antipsychotic-induced hippocampal acetylcholine release - Johnson_2005_Eur.J.Pharmacol_506_209
Author(s) : Johnson DE , Nedza FM , Spracklin DK , Ward KM , Schmidt AW , Iredale PA , Godek DM , Rollema H
Ref : European Journal of Pharmacology , 506 :209 , 2005
PubMedID: 15627430

Title : Early biochemical detection of delayed neurotoxicity resulting from developmental exposure to chloropyrifos - Johnson_1998_Brain.Res.Bull_45_143
Author(s) : Johnson DE , Seidler FJ , Slotkin TA
Ref : Brain Research Bulletin , 45 :143 , 1998
PubMedID: 9443830